Stephen H. Rusckowski's Insider Trades & SAST Disclosures
Stephen H. Rusckowski's most recent trade in Tenet Healthcare Corp. was a trade of 1,551 Restricted Stock Units done . Disclosure was reported to the exchange on May 23, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen H. Rusckowski.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenet Healthcare Corp. | Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,551 | 1,551 | - | - | Restricted Stock Units | |
| Baxter International Inc. | Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 9,068 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International Inc. | Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 3,049 | 3,049 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Tenet Healthcare Corp. | Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 3,682 | 3,682 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 2,846 | 2,846 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 147.86 per share. | 06 Mar 2023 | 82,631 | 428,201 (0%) | 0% | 147.9 | 12,217,820 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 06 Mar 2023 | 38,604 | 389,597 (0%) | 0% | 147.9 | 5,707,987 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.69 per share. | 01 Mar 2023 | 3,496 | 345,570 (0%) | 0% | 140.7 | 491,852 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,059 | 349,066 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 23 Feb 2023 | 5,826 | 329,007 (0%) | 0% | 147.9 | 861,432 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 14,854 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.63 per share. | 25 May 2022 | 14,854 | 349,687 (0%) | 0% | 86.6 | 1,286,802 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.57 per share. | 25 May 2022 | 10,037 | 344,870 (0%) | 0% | 103.6 | 1,039,532 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 10,037 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.58 per share. | 25 May 2022 | 9,823 | 339,864 (0%) | 0% | 140.6 | 1,380,927 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.60 per share. | 25 May 2022 | 6,821 | 338,049 (0%) | 0% | 140.6 | 959,046 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 141.35 per share. | 25 May 2022 | 4,131 | 335,733 (0%) | 0% | 141.3 | 583,909 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 141.36 per share. | 25 May 2022 | 2,565 | 335,484 (0%) | 0% | 141.4 | 362,591 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 142.13 per share. | 25 May 2022 | 900 | 334,833 (0%) | 0% | 142.1 | 127,921 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 142.15 per share. | 25 May 2022 | 651 | 334,833 (0%) | 0% | 142.2 | 92,540 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.63 per share. | 23 May 2022 | 156,282 | 491,115 (0%) | 0% | 86.6 | 13,538,710 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.12 per share. | 23 May 2022 | 156,282 | 334,833 (0%) | 0% | 140.1 | 21,898,546 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 156,282 | 14,854 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 126,126 | 10,037 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.57 per share. | 23 May 2022 | 126,126 | 460,959 (0%) | 0% | 103.6 | 13,062,870 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.12 per share. | 23 May 2022 | 126,126 | 334,833 (0%) | 0% | 140.1 | 17,672,775 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.63 per share. | 23 May 2022 | 42,568 | 377,401 (0%) | 0% | 86.6 | 3,687,666 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 42,568 | 171,136 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.12 per share. | 23 May 2022 | 41,268 | 336,133 (0%) | 0% | 140.1 | 5,782,431 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.57 per share. | 23 May 2022 | 34,898 | 369,731 (0%) | 0% | 103.6 | 3,614,386 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 34,898 | 136,163 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.12 per share. | 23 May 2022 | 33,898 | 335,833 (0%) | 0% | 140.1 | 4,749,923 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 141.51 per share. | 23 May 2022 | 1,000 | 335,133 (0%) | 0% | 141.5 | 141,509 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 141.54 per share. | 23 May 2022 | 800 | 335,033 (0%) | 0% | 141.5 | 113,234 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 142.24 per share. | 23 May 2022 | 300 | 334,833 (0%) | 0% | 142.2 | 42,672 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 142.26 per share. | 23 May 2022 | 200 | 334,833 (0%) | 0% | 142.3 | 28,451 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 130.09 per share. | 07 Mar 2022 | 70,184 | 367,403 (0%) | 0% | 130.1 | 9,130,237 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 07 Mar 2022 | 32,570 | 334,833 (0%) | 0% | 130.1 | 4,237,031 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 109,317 | 109,317 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 22,510 | 297,219 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 23 Feb 2022 | 7,463 | 276,964 (0%) | 0% | 130.1 | 970,862 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.23 per share. | 23 Feb 2022 | 2,255 | 274,709 (0%) | 0% | 130.2 | 293,669 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.14 per share. | 28 Jul 2021 | 139,751 | 284,427 (0%) | 0% | 140.1 | 19,584,845 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 139,751 | 9,493 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.79 per share. | 28 Jul 2021 | 139,751 | 424,178 (0%) | 0% | 95.8 | 13,387,447 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 5,300 | 4,193 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.59 per share. | 28 Jul 2021 | 5,300 | 284,427 (0%) | 0% | 140.6 | 745,132 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.80 per share. | 28 Jul 2021 | 5,300 | 289,727 (0%) | 0% | 95.8 | 507,714 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 4,193 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 141.22 per share. | 28 Jul 2021 | 4,193 | 284,427 (0%) | 0% | 141.2 | 592,119 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.79 per share. | 28 Jul 2021 | 4,193 | 288,620 (0%) | 0% | 95.8 | 401,668 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.79 per share. | 26 Jul 2021 | 32,788 | 317,215 (0%) | 0% | 95.8 | 3,140,926 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2021 | 32,788 | 149,244 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.01 per share. | 26 Jul 2021 | 32,788 | 284,427 (0%) | 0% | 140.0 | 4,590,550 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.79 per share. | 26 Jul 2021 | 5,813 | 290,240 (0%) | 0% | 95.8 | 556,856 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 140.03 per share. | 26 Jul 2021 | 5,813 | 284,427 (0%) | 0% | 140.0 | 813,994 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2021 | 5,813 | 182,032 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 115.42 per share. | 09 Mar 2021 | 58,368 | 310,314 (0%) | 0% | 115.4 | 6,736,835 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.42 per share. | 09 Mar 2021 | 25,887 | 284,427 (0%) | 0% | 115.4 | 2,987,878 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.15 per share. | 23 Feb 2021 | 4,033 | 255,265 (0%) | 0% | 121.2 | 488,598 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.19 per share. | 23 Feb 2021 | 3,319 | 251,946 (0%) | 0% | 121.2 | 402,230 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 120,901 | 120,901 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 21,551 | 259,298 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 16 Oct 2020 | 291,997 | 237,747 (0%) | 0% | 120 | 35,039,640 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2020 | 291,997 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.51 per share. | 16 Oct 2020 | 291,997 | 529,744 (0%) | 0% | 66.5 | 19,420,720 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.17 per share. | 27 Apr 2020 | 11,717 | 249,464 (0%) | 0% | 71.2 | 833,899 | Common Stock |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 11,717 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Stephen H. Rusckowski | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 112.01 per share. | 27 Apr 2020 | 11,717 | 237,747 (0%) | 0% | 112.0 | 1,312,433 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges